Reply

Affiliations

¹ Institut Mondor de Recherche Biomédicale, Université Paris-Est Créteil, INSERM, Créteil, France.
² Institut Mondor de Recherche Biomédicale, Université Paris-Est Créteil, INSERM, Créteil, France, Centre de Reference pour les Maladies Neuromusculaires, of Nord-Est-Île de France, and Hôpital Henri-Mondor, AP-HP, FILNEMUS, Paris, France.
³ Institut Mondor de Recherche, Biomédicale, Université, Paris-Est Créteil, INSERM, Créteil, France, Centre de Reference pour les Maladies Neuromusculaires, of Nord-Est-Île de France, and Hôpital Necker-Enfants Malades, AP-HP, FILNEMUS, Paris, France.

Comment

Cyrielle Hou et al. Arthritis Rheumatol. 2021 Aug.

. 2021 Aug;73(8):1566-1567.

doi: 10.1002/art.41706. Epub 2021 Jul 9.

¹ Institut Mondor de Recherche Biomédicale, Université Paris-Est Créteil, INSERM, Créteil, France.
² Institut Mondor de Recherche Biomédicale, Université Paris-Est Créteil, INSERM, Créteil, France, Centre de Reference pour les Maladies Neuromusculaires, of Nord-Est-Île de France, and Hôpital Henri-Mondor, AP-HP, FILNEMUS, Paris, France.
³ Institut Mondor de Recherche, Biomédicale, Université, Paris-Est Créteil, INSERM, Créteil, France, Centre de Reference pour les Maladies Neuromusculaires, of Nord-Est-Île de France, and Hôpital Necker-Enfants Malades, AP-HP, FILNEMUS, Paris, France.

No abstract available

Comment on

From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies.
Hou C, Durrleman C, Periou B, Barnerias C, Bodemer C, Desguerre I, Quartier P, Melki I, Rice GI, Rodero MP, Charuel JL, Relaix F, Bader-Meunier B, Authier F, Gitiaux C. Hou C, et al. Arthritis Rheumatol. 2021 Jun;73(6):1044-1052. doi: 10.1002/art.41625. Epub 2021 Apr 26. Arthritis Rheumatol. 2021. PMID: 33314705
Myositis-Specific Autoantibodies as Relevant Adjusting Variables in Myositis Research: Comment on the Article by Hou et al.
Pinal-Fernandez I, Mammen AL. Pinal-Fernandez I, et al. Arthritis Rheumatol. 2021 Aug;73(8):1564-1566. doi: 10.1002/art.41705. Epub 2021 Jul 9. Arthritis Rheumatol. 2021. PMID: 33645884 Free PMC article. No abstract available.

1. Mammen AL, Allenbach Y, Stenzel W, Benveniste O, Allenbach DY, Benveniste DO, et al. 239th ENMC International Workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018. Neuromuscul Disord 2020;30:70-92.
1. O’Connor KA, Abbott KA, Sabin B, Kuroda M, Pachman LM. MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement. Clin Immunol 2006;120:319-25.
1. Moneta GM, Pires Marafon D, Marasco E, Rosina S, Verardo M, Fiorillo C, et al. Muscle expression of type I and type II interferons is increased in juvenile dermatomyositis and related to clinical and histologic features. Arthritis Rheumatol 2019;71:1011-21.
1. Pinal-Fernandez I, Casal-Dominguez M, Derfoul A, Pak K, Plotz P, Miller FW, et al. Identification of distinctive interferon gene signatures in different types of myositis. Neurology 2019;93:e1193-204.
1. Melki I, Devilliers H, Gitiaux C, Bondet V, Duffy D, Charuel JL, et al. Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling. Rheumatology (Oxford) 2020;59:1927-37.